Daxdilimab, CAS 2245966-28-1

Product Description: Daxdilimab is an anti-ILT7 monoclonal antibody, ILT7 is a cell surface molecule specific to the pDC type of dendritic cells. Daxdilimab can be used in acute lung injury (ALI) in patients with COVID-19 infection research[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Patel S, et al. Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19. Heliyon. 2021 Feb;7(2):e06158./[2]Retamozo S, et al. An update of targeted therapeutic options for primary Sjögren syndrome: current status and future development. Expert Opin Pharmacother. 2021 Dec;22(17):2359-2371.

CAS Number: 2245966-28-1

Molecular Weight: N/A

Compound Purity: 95.0

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: SARS-CoV

• Artikelnummer: MEXHY-P99226-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99226-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK